 Nilotinib has been reported as a substrate for OATP1B1 and OATP1B3.Interaction of nilotinib with OATP1B1 and OATP1B3 may alter its hepatic disposition and can lead to transporter mediated drug-drug interactions.Nilotinib is an inhibitor of OATP-1B1 transporter but not for OATP-1B3.